Genotype and Phenotype Registry: Enrollment of Normal Control Subjects for Current and Future Research

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Peter Gregersen, North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT00926042
First received: June 19, 2009
Last updated: January 23, 2013
Last verified: January 2013
  Purpose

Registry program for volunteers who are willing to serve as control subjects in future research studies.


Condition
Healthy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: TAP0307: Enrollment of Normal Control Subjects for Current and Future Research

Further study details as provided by North Shore Long Island Jewish Health System:

Biospecimen Retention:   Samples With DNA

Cheek cell DNA sample will be collected


Enrollment: 4511
Study Start Date: February 2004
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Detailed Description:

The registry is a collection of volunteers willing to participate as control subjects in research studies. Control subjects are people who do not have a specific disease; therefore they can serve a critical role as a comparison with people who have the disease or other characteristic being studied. Once registered, participants will be notified about studies they may be able to participate in as a control.

Participation requires:

  1. signing a consent form
  2. answering a short health survey
  3. providing a DNA sample via a mouthwash kit

The registry allows scientists to select study participants based on whether or not they have a specific genetic change that may be relevant to a disease under investigation. Having the ability to access controls when needed is an extremely valuable resource that will speed up scientific discoveries.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

New York City/ Long Island metropolitan community

Criteria

Inclusion Criteria:

  • Generally healthy
  • over age 18

Exclusion Criteria:

  • under age 18
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00926042

Locations
United States, New York
The Feinstein Institute for Medical Research
Manhasset, New York, United States, 11030
Sponsors and Collaborators
North Shore Long Island Jewish Health System
Investigators
Principal Investigator: Peter K Gregersen, MD North Shore Long Island Jewish Health System
  More Information

No publications provided

Responsible Party: Peter Gregersen, Center Head, North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier: NCT00926042     History of Changes
Other Study ID Numbers: 04-007
Study First Received: June 19, 2009
Last Updated: January 23, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by North Shore Long Island Jewish Health System:
Healthy
volunteer
Healthy controls
Normal controls

ClinicalTrials.gov processed this record on April 17, 2014